Vetoquinol SA (LON:0O1O)

Market Cap	777.72M
Revenue (ttm)	445.90M
Net Income (ttm)	48.54M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	16.02
Forward PE	n/a
Dividend	0.72 (0.93%)
Ex-Dividend Date	Jun 4, 2025

Volume	8
Average Volume	1,756
Open	78.00
Previous Close	77.70
Day's Range	77.40 - 78.00
52-Week Range	76.60 - 108.99
Beta	0.88
RSI	51.48
Earnings Date	Apr 24, 2025

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1933
• Employees: 2,440
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O1O

Financial Performance

In 2024, Vetoquinol's revenue was 539.20 million, an increase of 1.88% compared to the previous year's 529.27 million. Earnings were 58.70 million, an increase of 5.65%.

Financial numbers in EUR